Teva Pharmaceutical Finance Netherlands IV BV

Deals

CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
CHF300.0002Jul-18-Baa2BBB-FixedSwaps-0.15% a86.30.13%-100.00000
CHF350.0006Jul-22Sr. UnsecuredBaa2BBB-FixedSwaps-MS+110 a1050.50%-100.22100
CHF350.0009Jul-25Sr. UnsecuredBaa2BBB-FixedSwaps-MS+140 a1351%-100.25700
Tranche Comments
2 yr: Comments: CHF300m no-grow exp 0.15% 2yr. Baa2/BBB. BNPP/BAML/Barc/CS/HSBC/Miz. Guidance MS+89.5 area / 0.15% ytm, tbp 0.125% coupon/ytm.; 6 yr: Comments: CHF350m no-grow 0.5% 6yr. Baa2/BBB. BNPP/BAML/Barc/CS/HSBC/Miz. Guidance MS+110 area / 0.5% ytm, final +105. TBP today.; 9 yr: Comments: CHF350m no-grow 1.125% 9yr. Baa2/BBB. BNPP/BAML/Barc/CS/HSBC/Miz. Guidance MS+140 area / 1.125% ytm, final +135. TBP today.;
Guarantor(s)
Teva Pharmaceutical Industries Limited

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research